Dhiraj Kumar

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Differentially regulated saliva proteome and metabolome: a way forward for risk-assessment of oral cancer among tobacco abusers
  Molecular Omics 2025 1 citation DOI: 10.1039/D5MO00058K
  +Save
• A clinical mutation inuvrA, a DNA repair gene, confers survival advantage toMycobacterium tuberculosisin the host
  2024 1 citation DOI: 10.1101/2024.10.07.616951
  +Save
• Actionable mechanisms of drug tolerance and resistance in Mycobacterium tuberculosis
  The FEBS Journal 2024 37 citations DOI: 10.1111/febs.17142
  +Save
• Host-directed therapy against tuberculosis: Concept and recent developments
  Journal of Biosciences 2023 14 citations DOI: 10.1007/s12038-023-00374-y
  +Save
• Phosphorylation of CFP10 modulates Mycobacterium tuberculosis virulence
  mBio 2023 12 citations DOI: 10.1128/mbio.01232-23
  +Save
• Structural investigation on SPI‐6–associated Salmonella typhimuriumVirG‐like stress protein that promotes pathogen survival in macrophages
  Protein Science 2022 7 citations DOI: 10.1002/pro.4272
  +Save
• Compromised base excision repair pathway in Mycobacterium tuberculosis imparts superior adaptability in the host.
  PLoS pathogens 2021 24 citations DOI: 10.1371/journal.ppat.1009452
  +Save
• Trehalose limits opportunistic mycobacterial survival during HIV co-infection by reversing HIV-mediated autophagy block
  Autophagy 2021 59 citations DOI: 10.1080/15548627.2020.1725374
  +Save
• Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosis
  Nature Communications 2020 67 citations DOI: 10.1038/s41467-020-16877-3
  +Save
• Mesenchymal stem cells (MSCs) offer a drug tolerant and immune- privileged niche to Mycobacterium tuberculosis
  2019 0 citations DOI: 10.1101/521609
  +Save